Adage Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $268M | Sell |
545,832
-18,336
| -3% | -$9.95M | 0.41% | 44 |
|
|
2025
Q4 | $327M | Buy |
564,168
+25,288
| +5% | +$14.3M | 0.49% | 28 |
|
|
2025
Q3 | $261M | Buy |
538,880
+213,156
| +65% | +$99.2M | 0.41% | 32 |
|
|
2025
Q2 | $132M | Buy |
325,724
+92,272
| +40% | +$38.6M | 0.22% | 84 |
|
|
2025
Q1 | $116M | Sell |
233,452
-156,863
| -40% | -$85M | 0.22% | 94 |
|
|
2024
Q4 | $203M | Buy |
390,315
+32,591
| +9% | +$17.9M | 0.36% | 41 |
|
|
2024
Q3 | $221M | Buy |
357,724
+5,814
| +2% | +$3.44M | 0.39% | 38 |
|
|
2024
Q2 | $195M | Sell |
351,910
-64,312
| -15% | -$36.8M | 0.36% | 43 |
|
|
2024
Q1 | $242M | Buy |
416,222
+20,121
| +5% | +$11.3M | 0.46% | 33 |
|
|
2023
Q4 | $210M | Buy |
396,101
+61,977
| +19% | +$30M | 0.44% | 37 |
|
|
2023
Q3 | $169M | Buy |
334,124
+18,739
| +6% | +$9.99M | 0.38% | 47 |
|
|
2023
Q2 | $165M | Sell |
315,385
-88,719
| -22% | -$47.9M | 0.36% | 58 |
|
|
2023
Q1 | $233M | Buy |
404,104
+5,180
| +1% | +$2.92M | 0.52% | 29 |
|
|
2022
Q4 | $220M | Sell |
398,924
-200
| -0.1% | -$106K | 0.53% | 27 |
|
|
2022
Q3 | $202M | Buy |
399,124
+11,700
| +3% | +$6.55M | 0.5% | 27 |
|
|
2022
Q2 | $210M | Sell |
387,424
-24,100
| -6% | -$13.3M | 0.48% | 30 |
|
|
2022
Q1 | $243M | Buy |
411,524
+34,900
| +9% | +$20M | 0.46% | 34 |
|
|
2021
Q4 | $251M | Sell |
376,624
-45,400
| -11% | -$28.3M | 0.45% | 40 |
|
|
2021
Q3 | $241M | Buy |
422,024
+13,600
| +3% | +$7.46M | 0.47% | 37 |
|
|
2021
Q2 | $206M | Sell |
408,424
-27,458
| -6% | -$13M | 0.4% | 48 |
|
|
2021
Q1 | $199M | Buy |
435,882
+19,600
| +5% | +$9.36M | 0.41% | 47 |
|
|
2020
Q4 | $194M | Sell |
416,282
-26,507
| -6% | -$12.4M | 0.42% | 39 |
|
|
2020
Q3 | $196M | Sell |
442,789
-14,500
| -3% | -$5.99M | 0.49% | 37 |
|
|
2020
Q2 | $166M | Sell |
457,289
-107,200
| -19% | -$35.9M | 0.42% | 45 |
|
|
2020
Q1 | $160M | Buy |
564,489
+97,003
| +21% | +$30.6M | 0.48% | 40 |
|
|
2019
Q4 | $152M | Sell |
467,486
-20,552
| -4% | -$6.23M | 0.37% | 57 |
|
|
2019
Q3 | $142M | Sell |
488,038
-2,957
| -0.6% | -$847K | 0.35% | 67 |
|
|
2019
Q2 | $144M | Buy |
490,995
+10,971
| +2% | +$3.02M | 0.36% | 66 |
|
|
2019
Q1 | $131M | Buy |
480,024
+4,430
| +0.9% | +$1.1M | 0.33% | 80 |
|
|
2018
Q4 | $106M | Sell |
475,594
-43,397
| -8% | -$10.2M | 0.29% | 94 |
|
|
2018
Q3 | $127M | Sell |
518,991
-15,590
| -3% | -$3.59M | 0.28% | 96 |
|
|
2018
Q2 | $111M | Sell |
534,581
-5,451
| -1% | -$1.16M | 0.25% | 98 |
|
|
2018
Q1 | $111M | Buy |
540,032
+221,227
| +69% | +$46.4M | 0.26% | 102 |
|
|
2017
Q4 | $60.5M | Sell |
318,805
-554,900
| -64% | -$106M | 0.14% | 189 |
|
|
2017
Q3 | $165M | Buy |
873,705
+352,100
| +68% | +$63.8M | 0.4% | 49 |
|
|
2017
Q2 | $91M | Sell |
521,605
-409,309
| -44% | -$68.8M | 0.22% | 131 |
|
|
2017
Q1 | $143M | Buy |
930,914
+366,009
| +65% | +$55.9M | 0.36% | 70 |
|
|
2016
Q4 | $79.7M | Buy |
564,905
+68,744
| +14% | +$10.1M | 0.22% | 126 |
|
|
2016
Q3 | $78.9M | Sell |
496,161
-90,200
| -15% | -$13.9M | 0.22% | 126 |
|
|
2016
Q2 | $86.6M | Sell |
586,361
-4,403
| -0.7% | -$650K | 0.24% | 119 |
|
|
2016
Q1 | $83.6M | Sell |
590,764
-383,800
| -39% | -$51.4M | 0.23% | 125 |
|
|
2015
Q4 | $138M | Buy |
974,564
+7,300
| +0.8% | +$974K | 0.36% | 76 |
|
|
2015
Q3 | $118M | Buy |
967,264
+247,600
| +34% | +$32.3M | 0.33% | 80 |
|
|
2015
Q2 | $93.4M | Sell |
719,664
-170,265
| -19% | -$22.2M | 0.23% | 121 |
|
|
2015
Q1 | $120M | Buy |
889,929
+385,265
| +76% | +$49.7M | 0.29% | 93 |
|
|
2014
Q4 | $63.2M | Sell |
504,664
-103,141
| -17% | -$12.5M | 0.15% | 180 |
|
|
2014
Q3 | $74M | Buy |
607,805
+191,800
| +46% | +$23.3M | 0.18% | 159 |
|
|
2014
Q2 | $49.1M | Sell |
416,005
-477,700
| -53% | -$56.2M | 0.13% | 215 |
|
|
2014
Q1 | $107M | Buy |
893,705
+93,200
| +12% | +$11.1M | 0.29% | 96 |
|
|
2013
Q4 | $89.1M | Sell |
800,505
-607,400
| -43% | -$60.4M | 0.24% | 125 |
|
|
2013
Q3 | $130M | Buy |
1,407,905
+659,626
| +88% | +$59.7M | 0.37% | 72 |
|
|
2013
Q2 | $63.3M | Buy |
+748,279
| New | +$62.3M | 0.2% | 154 |
|
Other funds holding TMO
VCM
Adage Capital Partners's TMO Position: Q1 2026 in Review
Adage Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.3% in Q1 2026, selling an estimated $9.95M and leaving 545,832 shares worth $268M. The position accounts for 0.41% of the portfolio, ranked #44.
Adage Capital Partners first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $327M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Adage Capital Partners held 545,832 shares of Thermo Fisher Scientific worth $268M as of Q1 2026.
- Adage Capital Partners sold 18,336 Thermo Fisher Scientific shares in Q1 2026, an estimated $9.95M.
- Thermo Fisher Scientific made up 0.41% of Adage Capital Partners's portfolio in Q1 2026, its #44 holding.
- Adage Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Adage Capital Partners's Thermo Fisher Scientific position peaked at $327M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.